Human Longevity, a San Francisco, CA-based longevity centered expertise firm, raised $39.8M in Collection B funding.
The spherical was led by TVM Capital Healthcare with participation from new and current traders, together with Panacea Enterprise and Rising Expertise Companions.
The corporate intends to make use of the funds to spend money on its synthetic intelligence well being threat and suggestion platform, new longevity centered applied sciences and providers, and new enlargement websites globally.
Human Longevity is advancing human longevity care to find and harness the technological and organic interventions that amplify span of life, well being, & high-performance. By frequently including and analyzing its consumer’s well being information, the corporate is innovating therapy from a reactive apply to at least one that’s proactive, preventative, and customized.
As results of analysis, they’ve created a 100+ Longevity care membership program to determine early phases of the most important age-related well being illnesses, with the objective to extend healthspan and prolong lifespan via the corporate’s medical care group and information platform.
The 100+ Longevity Care program leverages precision drugs well being information, medical care, focused interventions and this system additionally focuses on lowering organic age. Key elements embrace complete genome sequencing, whole-body and mind MRI, complete cardiac analysis, physique composition evaluation, superior blood biomarkers, and wearables.
FinSMEs
22/08/2024
